144 related articles for article (PubMed ID: 32811267)
1. Altered levels of circulating natural antibodies against VEGFR1-derived peptide in atherosclerosis.
Wang P; Liu S; Wang Z; Zhao H; Zhang X
J Int Med Res; 2020 Aug; 48(8):300060520948750. PubMed ID: 32811267
[TBL] [Abstract][Full Text] [Related]
2. Detection of circulating natural antibodies against CD25, MUC1, and VEGFR1 for early diagnosis of non-small cell lung cancer.
Liu S; Zhang X; Jiang Q; Liang T
FEBS Open Bio; 2020 Jul; 10(7):1288-1294. PubMed ID: 32392378
[TBL] [Abstract][Full Text] [Related]
3. Further analysis of natural antibodies against ischemic stroke.
Qi J; Jiang Q; Wang P; Wang Z; Zhang X
Front Neurol; 2023; 14():1130748. PubMed ID: 36741286
[TBL] [Abstract][Full Text] [Related]
4. Circulating natural antibodies to inflammatory cytokines are potential biomarkers for atherosclerosis.
Wang P; Zhao H; Wang Z; Zhang X
J Inflamm (Lond); 2018; 15():22. PubMed ID: 30479572
[TBL] [Abstract][Full Text] [Related]
5. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
[TBL] [Abstract][Full Text] [Related]
6. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
Fischer K
Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
[TBL] [Abstract][Full Text] [Related]
7. Study of natural IgG antibodies against vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
Wang Y; Yan Z; Huang Y; Qiu C; Chen X; Hu Y; Meng Q; Wei J
Am J Cancer Res; 2017; 7(3):603-609. PubMed ID: 28401015
[TBL] [Abstract][Full Text] [Related]
8. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor receptor 1 tyrosine kinase signaling facilitates healing of DSS-induced colitis by accumulation of Tregs in ulcer area.
Betto T; Amano H; Ito Y; Eshima K; Yoshida T; Matsui Y; Yamane S; Inoue T; Otaka F; Kobayashi K; Koizumi W; Shibuya M; Majima M
Biomed Pharmacother; 2019 Mar; 111():131-141. PubMed ID: 30579252
[TBL] [Abstract][Full Text] [Related]
10. VEGFR1 and VEGFR2 in Alzheimer's Disease.
Harris R; Miners JS; Allen S; Love S
J Alzheimers Dis; 2018; 61(2):741-752. PubMed ID: 29226875
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis.
Shibuya M
J Biochem Mol Biol; 2006 Sep; 39(5):469-78. PubMed ID: 17002866
[TBL] [Abstract][Full Text] [Related]
12. Expression of VEGF and its receptors VEGFR1/VEGFR2 is associated with invasiveness of bladder cancer.
Kopparapu PK; Boorjian SA; Robinson BD; Downes M; Gudas LJ; Mongan NP; Persson JL
Anticancer Res; 2013 Jun; 33(6):2381-90. PubMed ID: 23749886
[TBL] [Abstract][Full Text] [Related]
13. VEGF165b Modulates Endothelial VEGFR1-STAT3 Signaling Pathway and Angiogenesis in Human and Experimental Peripheral Arterial Disease.
Ganta VC; Choi M; Kutateladze A; Annex BH
Circ Res; 2017 Jan; 120(2):282-295. PubMed ID: 27974423
[TBL] [Abstract][Full Text] [Related]
14. Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients.
Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
Melanoma Res; 2006 Oct; 16(5):405-11. PubMed ID: 17013089
[TBL] [Abstract][Full Text] [Related]
15. Seropositivity for anti-Borrelia IgG antibody is independently associated with carotid atherosclerosis.
Völzke H; Wolff B; Lüdemann J; Guertler L; Kramer A; John U; Felix SB
Atherosclerosis; 2006 Jan; 184(1):108-12. PubMed ID: 16326170
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor receptor 1 expression in nasal polyp tissue.
Bobic S; Hox V; Callebaut I; Vinckier S; Jonckx B; Stassen JM; Jorissen M; Gevaert P; Carmeliet P; Bachert C; Ceuppens JL; Hellings PW
Allergy; 2014 Feb; 69(2):237-45. PubMed ID: 24127643
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic VEGF
Ganta VC; Choi M; Farber CR; Annex BH
Circulation; 2019 Jan; 139(2):226-242. PubMed ID: 30586702
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
Gebhardt M; Mentlein R; Schaudig U; Pufe T; Recker K; Nölle B; Al-Samir K; Geerling G; Paulsen FP
Ophthalmology; 2005 Jun; 112(6):1023-30. PubMed ID: 15885787
[TBL] [Abstract][Full Text] [Related]
19. Decreased Expression of Vascular Endothelial Growth Factor Receptor 1 Contributes to the Pathogenesis of Hereditary Hemorrhagic Telangiectasia Type 2.
Thalgott JH; Dos-Santos-Luis D; Hosman AE; Martin S; Lamandé N; Bracquart D; Srun S; Galaris G; de Boer HC; Tual-Chalot S; Kroon S; Arthur HM; Cao Y; Snijder RJ; Disch F; Mager JJ; Rabelink TJ; Mummery CL; Raymond K; Lebrin F
Circulation; 2018 Dec; 138(23):2698-2712. PubMed ID: 30571259
[TBL] [Abstract][Full Text] [Related]
20. Targeting signaling pathways of VEGFR1 and VEGFR2 as a potential target in the treatment of breast cancer.
Farzaneh Behelgardi M; Zahri S; Gholami Shahvir Z; Mashayekhi F; Mirzanejad L; Asghari SM
Mol Biol Rep; 2020 Mar; 47(3):2061-2071. PubMed ID: 32072404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
